PAPER Mielke MM, Fowler NR, Whitson HE, Klepin HD, Trammell AR, Kulshreshtha A, O'Brien KS, Manchester M, Salive ME, Williamson J
SEARCH RESULTS
347548 RESULTS
PAPER Liew TM
Distinct trajectories of subjective cognitive decline before diagnosis of neurocognitive disorders: Longitudinal modelling over 18 years.
J Prev Alzheimers Dis. 2025 Mar 7;:100123. Epub 2025 Mar 7 PubMed.PAPER Rahman AU, Ali S, Saqia B, Halim Z, Al-Khasawneh MA, AlHammadi DA, Khan MZ, Ullah I, Alharbi M
Alzheimer's Disease Prediction Using 3D-CNNs: Intelligent Processing of Neuroimaging Data.
SLAS Technol. 2025 Mar 6;:100265. Epub 2025 Mar 6 PubMed.PAPER Mielke MM, Fielding RA, Atkinson EJ, Aversa Z, Schafer MJ, Cummings SR, Pahor M, Leeuwenburgh C, LeBrasseur NK
Biomarkers of cellular senescence predict risk of mild cognitive impairment: Results from the lifestyle interventions for elders (LIFE) study.
J Nutr Health Aging. 2025 Mar 7;29(5):100529. Epub 2025 Mar 7 PubMed.PAPER Gong Y, Chen H, Gu Y, Shen J, Shen T, Ding Y, Lu M, Huang L, Yan M, Song P, Zhu Y, Rong S, Yuan C
Healthy dietary patterns in relation to cognitive performance and Alzheimer's disease mortality.
J Prev Alzheimers Dis. 2025 Mar 6;:100100. Epub 2025 Mar 6 PubMed.PAPER Veljanoska E, Gomes S, Szende A, Cabra A, Munter-Young R, Gordois A
The Value of Positron Emission Tomography for Confirmation of Alzheimer's Disease in the Era of Amyloid-Targeting Therapies.
Value Health. 2025 Mar 5; Epub 2025 Mar 5 PubMed.PAPER Zheng M
Snapshot of disease continuum centered on Alzheimer's disease: Exploring modifiable risk factors.
Prog Neuropsychopharmacol Biol Psychiatry. 2025 Mar 5;138:111316. Epub 2025 Mar 5 PubMed.PAPER Chen H, Fang Z, Lin SL, Schachner M
L1CAM mimetic compound duloxetine improves cognitive impairment in 5xFAD mice and protects Aβ1-42-damaged HT22 cells.
Eur J Pharmacol. 2025 Mar 6;997:177476. Epub 2025 Mar 6 PubMed.PAPER Shahid F, Khan R, Mehmood A, Smadi AA, Ibrahim MM, Zheng Z
A Comprehensive Approach to Anticipating the Progression of Mild Cognitive Impairment.
Brain Res. 2025 Mar 6;:149549. Epub 2025 Mar 6 PubMed.PAPER Kicik A, Kurt E, Hari E, Ulasoglu-Yildiz Ç, Gurvit H, Demiralp T
Impact of amygdala functional connectivity on cognitive impairment in Alzheimer's disease.
Neurol Sci. 2025 Mar 8; Epub 2025 Mar 8 PubMed.PAPER Guo J, Wang P, Gong J, Sun W, Han X, Xu C, Shan A, Wang X, Luan H, Li S, Li R, Wen B, Chen R, Lv S, Wei C
The disease burden, risk factors and future predictions of Alzheimer's disease and other types of dementia in Asia from 1990 to 2021.
J Prev Alzheimers Dis. 2025 Mar 7;:100122. Epub 2025 Mar 7 PubMed.PAPER Leroy M, Aziz AL, Schraen S, Deramecourt V, Skrobala E, Lecerf S, Pasquier F, Huin V, Bertoux M, Lebouvier T
Comparing high and low amyloid producers in Alzheimer's disease: An in-depth analysis.
Rev Neurol (Paris). 2025 Mar 7; Epub 2025 Mar 7 PubMed.PAPER Zhang B, Chen L, Kang M, Ai L, Tao Y
Gegen Qinlian Decoction improves Alzheimer's disease through TLR4/NF-κB/NLRP3 pathway.
Tissue Cell. 2025 Mar 1;95:102818. Epub 2025 Mar 1 PubMed.PAPER Wang H, Chang TS, Dombroski BA, Cheng PL, Si YQ, Tucci A, Patil V, Valiente-Banuet L, Li C, Farrell K, Mclean C, Molina-Porcel L, Rajput A, De Deyn PP, Le Bastard N, Gearing M, Donker Kaat L, Van Swieten JC, Dopper E, Ghetti BF, Newell KL, Troakes C, de Yébenes JG, Rábano-Gutierrez A, Meller T, Oertel WH, Respondek G, Stamelou M, Arzberger T, Roeber S, Müller U, Hopfner F, Pastor P, Brice A, Durr A, Le Ber I, Beach TG, Serrano GE, Hazrati LN, Litvan I, Rademakers R, Ross OA, Galasko D, Boxer AL, Miller BL, Seeley WW, Van Deerlin VM, Lee EB, White CL 3rd, Morris HR, de Silva R, Crary JF, Goate AM, Friedman JS, Compta Y, Leung YY, Coppola G, Naj AC, Wang LS, PSP Genetics Study Group, Dalgard C, Dickson DW, Höglinger GU, Tzeng JY, Geschwind DH, Schellenberg GD, Lee WP
Copy Number Variation and Haplotype Analysis of 17q21.31 Reveals Increased Risk Associated with Progressive Supranuclear Palsy and Gene Expression Changes in Neuronal Cells.
Mov Disord. 2025 Mar 8; Epub 2025 Mar 8 PubMed.PAPER Goldberg YP, Navon-Perry L, Cruz-Herranz A, Chen K, Hecker-Barth G, Spiegel K, Cohen Y, Niethammer M, Tan AM, Schuring H, Geva M, Hayden MR
The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease.
CNS Drugs. 2025 Mar 7; Epub 2025 Mar 7 PubMed.Current Filters
- Date Range : All x